Insilico Sees Rising Revenue From Deals With AI Firms

Alex Zhavoronkov, Founder & CEO at Insilico Medicine, discusses the AI-drug discovery firm's earnings and business outlook exclusively on "Bloomberg: The China Show." (Source: Bloomberg)

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.